"Levodopa is a replacement strategy. We all make levodopa, but Parkinson's patients make less of it," said Espay, ...

While the diagnosis of functional neurological disorder has increased exponentially, and psychotherapy is a commonly ...

“Levodopa is a replacement strategy. We all make levodopa, but Parkinson’s patients make less of it,” Dr. Alberto Espay, co-principal investigator of the trial and a physician at the ...

“Levodopa is a replacement strategy. We all make levodopa, but Parkinson's patients make less of it,” said Espay, co-principal investigator of the trial, James J. and Joan A. Gardner Family Center for ...

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...

She continued to dig into the subject and learn more while in high school, including connecting with Alberto Espay, MD, a UC Parkinson’s clinical researcher and physician. The COVID-19 pandemic ...

The Espay et al. study 4 also highlights a gulf in understanding between neurologists and psychiatrists, which might explain why these two disciplines often come to blows over patients with PMD ...

Alberto J. Espay, M.D., from the University of Cincinnati, and colleagues examined the safety and efficacy of a continuous 24-hour/day subcutaneous infusion of ND0612 compared with oral immediate ...

It can present with an array of neurological symptoms ranging from tics to non-epileptic seizures to periods of paralysis and hallucinations (Espay et al., 2018). While these symptoms may appear ...